Search clinical trials for: GSK221149

Total 4 results

GlaxoSmithKline

Completed

The Safety, Tolerability And Metabolism Of GSK221149A, In Pregnant Women (30-36 Weeks), In Pre-Term Labor

Obstetric Labour, Premature

United States, France, Bulgaria, Spain, Korea, Republic of, Singapore, Colombia, United Kingdom, Lithuania, Puerto Rico, Argentina
GlaxoSmithKline

Terminated

A Study To Assess The Pharmacokinetics Of Different Modified Release Formulations Of GSK221149 In Healthy Adult Subjects

Premature Ejaculation | Obstetric Labour, Premature

United States
GlaxoSmithKline

Completed

A Two Cohort Study to Look at the Metabolites of GSK221149, the Metabolism of GSK221149 Administered With a High Fat Meal and With Ketoconazole

Obstetric Labour, Premature

United States
GlaxoSmithKline

Completed

Absorption, Distribution, Metabolism And Excretion Study For GSK221149A

Obstetric Labour, Premature | Premature Labor

United States

3

Subscribe